XML 78 R14.htm IDEA: XBRL DOCUMENT v2.4.1.9
STOCK-BASED COMPENSATION
12 Months Ended
Dec. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
STOCK-BASED COMPENSATION
STOCK-BASED COMPENSATION
The Company currently has one active plan, the Fourth Amended and Restated LendingTree 2008 Stock and Annual Incentive Plan (the "Equity Award Plan"), under which future awards may be granted, which currently covers outstanding stock options to acquire shares of the Company's common stock, restricted stock and RSUs, and provides for the future grants of these and other equity awards. Under the Equity Award Plan, the Company is authorized to grant stock options, restricted stock, RSUs and other equity-based awards for up to 4.35 million shares of LendingTree common stock to employees, officers and directors. This Equity Award Plan also governs certain equity awards of IAC that were converted into equity awards of LendingTree in connection with the spin-off.
The Equity Award Plan has a stated term of ten years and provides that the exercise price of stock options granted will not be less than the market price of the common stock on the grant date. The Equity Award Plan itself does not specify grant dates or vesting schedules, as those determinations are delegated to the Compensation Committee of the board of directors. Each grant agreement reflects the vesting schedule for that particular grant, as determined by the Compensation Committee. The Compensation Committee has the authority to modify the vesting provisions of an award.
Prior to the 2008 spin-off from IAC, employees received equity awards that were granted under various IAC stock and annual incentive plans. Upon spin-off, these IAC awards were converted into awards of both LendingTree and other former IAC companies, which vested in 2012.
Non-cash compensation related to equity awards is included in the following line items in the accompanying consolidated statements of operations and comprehensive income (in thousands):
 
Year Ended December 31,
 
2014
 
2013
 
2012
Cost of revenue
$
32

 
$
13

 
$
6

Selling and marketing expense
901

 
931

 
750

General and administrative expense
5,148

 
3,841

 
3,205

Product development
1,196

 
842

 
626

Restructuring and severance
169

 

 

Total non-cash compensation
$
7,446

 
$
5,627

 
$
4,587


For the years ended December 31, 2014, 2013 and 2012, the Company recognized no income tax benefit related to non-cash compensation due to its net operating losses and valuation allowance. As of December 31, 2014, there was approximately $10.9 million, $5.8 million and $2.2 million of unrecognized compensation cost, net of estimated forfeitures, related to stock options, RSUs and restricted stock, respectively. These costs are expected to be recognized over a weighted-average period of approximately 3.0 years for stock options, 1.7 years for RSUs and 1.9 years for restricted stock.
Stock Options
A summary of the changes in outstanding stock options is as follows:
 
Number of Options
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual
Term
 
Aggregate
Intrinsic
Value(a)
 
 
 
(per option)
 
(in years)
 
(in thousands)
Outstanding at December 31, 2013
1,038,999

 
$
8.98

 
 
 
 

Granted
1,106,791

 
26.73

 
 
 
 

Exercised
(8,361
)
 
13.58

 
 
 
 

Forfeited

 

 
 
 
 

Expired
(750
)
 
13.04

 
 
 
 

Outstanding at December 31, 2014
2,136,679

 
$
18.16

 
6.43
 
$
64,492

Options exercisable
983,107

 
$
9.07

 
3.63
 
$
38,602

(a)
The aggregate intrinsic value represents the total pre-tax intrinsic value (the difference between the Company's closing stock price of $48.34 on the last trading day of 2014 and the exercise price, multiplied by the number of shares covered by in-the-money options) that would have been received by the option holders had all option holders exercised their options on December 31, 2014. The intrinsic value changes based on the market value of the Company's common stock.
Upon exercise, the intrinsic value represents the pre-tax difference between the Company's closing stock price on the exercise date and the exercise price, multiplied by the number of stock options exercised. During the years ended December 31, 2014, 2013 and 2012, the total intrinsic value of stock options that were exercised was $0.2 million, $0.4 million and $0.3 million, respectively. Cash received from stock option exercises and the related actual tax benefit realized were $0.1 million and $0.1 million, respectively, for the year ended December 31, 2014.
During the years ended December 31, 2014 and 2012, the Company granted stock options with a weighted average grant date fair value per share of $11.22 and $3.63, respectively, of which the vesting periods include (a) three years from the grant date, (b) 25% and 75% over a period of 2.5 years and 3.5 years, respectively, and (c) two years from the grant date.
For purposes of determining stock-based compensation expense, the weighted average grant date fair value per share of the stock options was estimated using the Black-Scholes option pricing model, which requires the use of various key assumptions. The weighted average assumptions used are as follows:
 
Year Ended December 31,
 
2014
2012
Expected term (1)
5.75 - 6.63 years

7.0 years

Expected dividend (2)


Expected volatility (3)
36% - 64%

45
%
Risk-free interest rate (4)
1.81% - 2.13%

2.0
%
(1)
For the year ended December 31, 2014, the expected term of stock options granted was calculated using the 'Simplified Method', which utilizes the midpoint between the weighted average time of vesting and the end of the contractual term. This method was utilized for the stock options due to a lack of historical exercise behavior by the Company's employees. For the year ended December 31, 2012, the expected term of stock options granted was based on analyses of historical employee termination rates and option exercise patterns, giving consideration to expectations of future employee behavior.
(2)
For all stock options granted during the years ended December 31, 2014 and 2012, no dividends are expected to be paid over the contractual term of the stock options, resulting in a zero expected dividend rate.
(3)
The expected volatility rate is based on the historical volatility of the Company's common stock or a blended rate which includes the historical volatility of the Company's common stock and that of a peer group.
(4)
The risk-free interest rate is specific to the date of grant. The risk-free interest rate is based on U.S. Treasury yields for notes with comparable expected terms as the awards, in effect at the grant date.
As of December 31, 2014, the non-vested options are expected to vest over a weighted-average period of approximately 3.0 years. During the years ended December 31, 2014, 2013 and 2012, the total fair value of options vested was $0.4 million, $3.2 million and $0.3 million, respectively.
Restricted Stock Units
A summary of the changes in outstanding nonvested RSUs is as follows:
 
RSUs
 
RSUs
Performance Condition
 
Number of
Units
 
Weighted
Average Grant
Date Fair
Value
 
Number of
Units
 
Weighted
Average Grant
Date Fair
Value
 
 
 
(per unit)
 
 
 
(per unit)
Nonvested at December 31, 2013
599,122

 
$
14.15

 

 
$

Granted (a)
135,607

 
32.33

 
500

 
33.59

Vested
(328,681
)
 
12.08

 
(500
)
 
33.59

Forfeited
(54,247
)
 
16.31

 

 

Nonvested at December 31, 2014
351,801

 
$
22.83

 

 
$

(a)
The grant date fair value per share of the RSUs is calculated as the closing market price of LendingTree's common stock at the time of the grant.
The total fair value of RSUs that vested during the years ended December 31, 2014, 2013 and 2012 was $11.0 million, $7.5 million and $4.3 million, respectively. The total fair value of RSUs with a performance condition that vested during the year ended December 31, 2014 was $22,000.
Restricted Stock
A summary of the changes in outstanding nonvested restricted stock is as follows:
 
Restricted Stock
 
Restricted Stock
Market Condition
 
Number of
Shares
 
Weighted
Average Grant
Date Fair
Value
 
Number of
Shares
 
Weighted
Average Grant
Date Fair
Value
 
 
 
(per share)
 
 
 
(per share)
Nonvested at December 31, 2013
119,500

 
$
22.47

 
62,500

 
$
13.93

Granted (a)(b)
43,389

 
25.14

 

 

Vested
(39,832
)
 
22.47

 
(62,500
)
 
13.93

Forfeited

 

 

 

Nonvested at December 31, 2014
123,057

 
$
23.41

 

 
$

(a)
The grant date fair value per share of the restricted stock is calculated as the closing market price of LendingTree's common stock at the time of grant.
(b)
The grant date fair value per share of the restricted stock with an underlying market condition was calculated using a Monte Carlo simulation model. These shares vest based on the achievement of a market-based performance target within three years, but not earlier than one year from the grant date. The fair value on grant date is recognized over the requisite service period.
The total fair value of restricted stock that vested during the years ended December 31, 2014, 2013 and 2012 was $1.5 million, $3.2 million and $0.8 million, respectively. The total fair value of restricted stock with a market condition that vested during the year ended December 31, 2014 was $2.1 million.